Shoreline Biosciences and BeiGene Announce Global Strategic Collaboration to Develop and Commercialize Genetically Engineered Natural Killer (NK) Cell Therapies
SAN DIEGO & CAMBRIDGE, MA & BEIJING–(BUSINESS WIRE)–Shoreline Biosciences, Inc.a biotechnology company that develops intelligently designed, standardized, and targeted allogeneic natural killer (NK) and macrophage cell immunotherapies derived from induced pluripotent stem cells (iPSCs) for cancer and other serious diseases, and BeiGene, Ltd. (Nasdaq: BGNE; HKEX: 06160), a global biotechnology company, today announced an exclusive […]
Shoreline Biosciences and BeiGene Announce Global Strategic Collaboration to Develop and Commercialize Genetically Engineered Natural Killer (NK) Cell Therapies
[ad_1] SAN DIEGO & CAMBRIDGE, Massachusetts & BEIJING – (COMMERCIAL THREAD) – Shoreline Biosciences, Inc., a biotechnology company developing ready-to-use, standardized and targeted allogeneic cellular immunotherapies and cellular macrophages derived from induced pluripotent stem cells (iPSCs) for cancer and other serious diseases, and BeiGene, Ltd. (Nasdaq: BGNE; HKEX: 06160), a global biotechnology company, today announced […]